Reporting Medical Malpractice Payments To The NPDB
September 10, 2011
The stated reasons behind the law that created the National Practitioner Data Bank were the increasing incidents of medical malpractice litigation and the need to improve the quality of medical care that became a national problem that required greater efforts than could be undertaken by the indivi[...]
Continue Reading
An Analysis Of Wrong Site And Wrong Patient Surgeries
September 8, 2011
A study reported in 2010 of wrong site and wrong patient surgeries was based on an analysis of a database covering the period from January 1, 2002 to June 1, 2008 of a Colorado medical malpractice insurance company that insured approximately 6,000 physicians in Colorado. The database included [...]
Continue Reading
Statistics Regarding Neurosurgical Medical Malpractice Claims
September 7, 2011
In a recent review of data from a large national medical malpractice insurance company regarding closed neurosurgical medical malpractice claims made between January 1, 2004 and June 30, 2009, the researchers randomly selected and reviewed 90 cases. The plaintiffs in the 90 cases reviewed involved 5[...]
Continue Reading
FDA Updates Labeling For RECLAST
September 6, 2011
RECLAST (active ingredient zoledronic acid) is a prescription medication manufactured by Novartis Pharmaceuticals Corporation for the treatment and prevention of postmenopausal osteoporosis. On September 2, 2011, the U.S. Food and Drug Administration (FDA) issued a labeling update for Reclast to b[...]
Continue Reading
Labor Day Musings From Medical Malpractice Lawyers Dot Com
September 5, 2011
Labor Day in the United States is a federal holiday that is observed on the first Monday in September. Labor Day celebrates the economic and the social contributions of workers in the United States. We, at medicalmalpracticelawyers.com, wish to thank each and every worker in the United States who to[...]
Continue Reading
Issues With Surgical Mesh Used For Pelvic Organ Prolapse (POP)
September 4, 2011
Surgical mesh is a medical device made from porous absorbable or non-absorbable synthetic material or absorbable biologic material used during surgery to repair weakened or damaged tissue. In women with certain gynecological problems, surgical mesh is permanently implanted to reinforce the weakened [...]
Continue Reading
Diabetes Drug Actos May Increase Risk Of Bladder Cancer
September 2, 2011
Actos (pioglitazone as the single ingredient) is a prescription medication used in the treatment of diabetes. It is used to improve control of blood sugar in adults with type 2 diabetes mellitus. Medications containing pioglitazone (pioglitazone is the single ingredient in Actos) have been filled by[...]
Continue Reading
Cesarean Deliveries: New Recommendations To Prevent Blood Clots
August 31, 2011
One of the leading causes of maternal death in the United States is blood clots (thromboembolism) that can block the flow of blood to vital organs. Pregnancy is associated with a four-fold increase in the risk of thromboembolism, which may be due to slower blood flow, compression of the pelvic and o[...]
Continue Reading
FDA Issues Celexa (citalopram hydrobromide) Safety Announcement
August 30, 2011
Celexa (citalopram hydrobromide) is a brand-name prescription medication used to treat depression. Celexa is in a class of antidepressants called SSRIs (selective serotonin reuptake inhibitors). It works by increasing the amount of serotonin, a natural substance in the brain that helps maintain me[...]
Continue Reading
